Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the ECC Webcasts. By clicking the button below you are declaring and confirming that you are a healthcare professional.

You are here

The Which: Clinical Evidence and Ongoing Trials in Anti-Angiogenic Treatments - Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma

H. Wilke (Germany)

Hansjochen Wilke covers first-line chemotherapy for gastric and gastro-oesophageal junction adenocarcinoma. The presentation looks at significant clinical trials, their methodologies and results.